

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.38011938 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.83597210 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.82198622 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.72339783 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.43535011 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.43535011 |
| 7 | negative T cell selection (GO:0043383) | 5.30910179 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.22263909 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.11248692 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.11248692 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.11248692 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.11248692 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.11248692 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.11248692 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.07057569 |
| 16 | respiratory burst (GO:0045730) | 4.93756455 |
| 17 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.88300306 |
| 18 | response to peptidoglycan (GO:0032494) | 4.61741320 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.49484290 |
| 20 | regulation of mononuclear cell migration (GO:0071675) | 4.38027689 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 4.34497751 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.10189513 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02494655 |
| 24 | tolerance induction (GO:0002507) | 4.01007663 |
| 25 | regulation of monocyte chemotaxis (GO:0090025) | 4.00953523 |
| 26 | T cell selection (GO:0045058) | 3.99545468 |
| 27 | positive T cell selection (GO:0043368) | 3.95969891 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.92351170 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.91114925 |
| 30 | thymic T cell selection (GO:0045061) | 3.89926975 |
| 31 | granulocyte activation (GO:0036230) | 3.89650031 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.86874158 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.86236111 |
| 34 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.83403604 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.82305668 |
| 36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80965929 |
| 37 | regulation of T cell tolerance induction (GO:0002664) | 3.75522050 |
| 38 | interferon-gamma production (GO:0032609) | 3.73125767 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.70731148 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70591718 |
| 41 | neutrophil activation (GO:0042119) | 3.69939645 |
| 42 | cellular response to interleukin-15 (GO:0071350) | 3.68274729 |
| 43 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.68234268 |
| 44 | cellular extravasation (GO:0045123) | 3.62744085 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.62650393 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62347136 |
| 47 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.61782747 |
| 48 | eosinophil chemotaxis (GO:0048245) | 3.60922076 |
| 49 | mast cell activation (GO:0045576) | 3.60376840 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.59084254 |
| 51 | superoxide anion generation (GO:0042554) | 3.58369166 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 3.57437622 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 3.56856984 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.56556310 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 3.55526010 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.53908020 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.53627531 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.53627531 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53386595 |
| 60 | myeloid dendritic cell differentiation (GO:0043011) | 3.52740908 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.51286032 |
| 62 | reactive oxygen species biosynthetic process (GO:1903409) | 3.46897893 |
| 63 | response to interleukin-15 (GO:0070672) | 3.44575771 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.42274750 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.41755773 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40108072 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39852783 |
| 68 | response to host immune response (GO:0052572) | 3.39852783 |
| 69 | positive regulation of heat generation (GO:0031652) | 3.37228660 |
| 70 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.36628713 |
| 71 | natural killer cell mediated immunity (GO:0002228) | 3.36628713 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 3.36110295 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.34644411 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.34644411 |
| 75 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33163490 |
| 76 | B cell mediated immunity (GO:0019724) | 3.32867964 |
| 77 | regulation of fever generation (GO:0031620) | 3.32546260 |
| 78 | monocyte chemotaxis (GO:0002548) | 3.32200295 |
| 79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30917966 |
| 80 | T cell receptor signaling pathway (GO:0050852) | 3.29854926 |
| 81 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.29329812 |
| 82 | actin nucleation (GO:0045010) | 3.27053794 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 3.26666490 |
| 84 | sequestering of actin monomers (GO:0042989) | 3.26413483 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 3.25922482 |
| 86 | eosinophil migration (GO:0072677) | 3.25501357 |
| 87 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.24641897 |
| 88 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21306595 |
| 89 | regulation of tolerance induction (GO:0002643) | 3.20789088 |
| 90 | regulation of B cell differentiation (GO:0045577) | 3.20443495 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 3.19781351 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.19702559 |
| 93 | phagosome maturation (GO:0090382) | 3.19642638 |
| 94 | T cell costimulation (GO:0031295) | 3.18348251 |
| 95 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17186428 |
| 96 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.14084271 |
| 97 | lymphocyte chemotaxis (GO:0048247) | 3.13938681 |
| 98 | lymphocyte costimulation (GO:0031294) | 3.13912777 |
| 99 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.13163406 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12804029 |
| 101 | positive regulation of macrophage differentiation (GO:0045651) | 3.11687332 |
| 102 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.11421280 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10974352 |
| 104 | mature B cell differentiation involved in immune response (GO:0002313) | 3.10298515 |
| 105 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.08429229 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.08199312 |
| 107 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06354882 |
| 108 | leukocyte mediated cytotoxicity (GO:0001909) | 3.04367704 |
| 109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03226409 |
| 110 | response to host (GO:0075136) | 3.03226409 |
| 111 | response to host defenses (GO:0052200) | 3.03226409 |
| 112 | positive regulation of interleukin-2 production (GO:0032743) | 3.02645822 |
| 113 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.02611484 |
| 114 | positive regulation of interleukin-12 production (GO:0032735) | 3.02236987 |
| 115 | regulation of chemokine biosynthetic process (GO:0045073) | 3.01262543 |
| 116 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.01124870 |
| 117 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.98298569 |
| 118 | regulation of mast cell degranulation (GO:0043304) | 2.97360130 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.96786270 |
| 120 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.96036672 |
| 121 | regulation of cell killing (GO:0031341) | 2.95427894 |
| 122 | leukocyte aggregation (GO:0070486) | 2.93681000 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92998673 |
| 124 | regulation of histone phosphorylation (GO:0033127) | 2.92723583 |
| 125 | positive regulation of tolerance induction (GO:0002645) | 2.92303342 |
| 126 | cellular response to zinc ion (GO:0071294) | 2.91655778 |
| 127 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.91356244 |
| 128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91323943 |
| 129 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90643198 |
| 130 | positive regulation of humoral immune response (GO:0002922) | 2.90155610 |
| 131 | positive regulation of chemokine production (GO:0032722) | 2.88000690 |
| 132 | dendritic cell differentiation (GO:0097028) | 2.87469789 |
| 133 | microglial cell activation (GO:0001774) | 2.87224658 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.87123162 |
| 135 | regulation of mast cell activation (GO:0033003) | 2.85512267 |
| 136 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.85294196 |
| 137 | alpha-beta T cell differentiation (GO:0046632) | 2.85175769 |
| 138 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.84977469 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84557032 |
| 140 | detection of molecule of bacterial origin (GO:0032490) | 2.84342877 |
| 141 | macrophage activation (GO:0042116) | 2.83563453 |
| 142 | cellular response to type I interferon (GO:0071357) | 2.82671306 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.82671306 |
| 144 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.82631373 |
| 145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.82631373 |
| 146 | wound healing, spreading of epidermal cells (GO:0035313) | 2.82545806 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.81277889 |
| 148 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79251444 |
| 149 | negative regulation of T cell apoptotic process (GO:0070233) | 2.79076841 |
| 150 | Peyers patch development (GO:0048541) | 2.78613879 |
| 151 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.78613879 |
| 152 | cellular defense response (GO:0006968) | 2.78461027 |
| 153 | alpha-beta T cell activation (GO:0046631) | 2.78399981 |
| 154 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78258453 |
| 155 | response to type I interferon (GO:0034340) | 2.77970635 |
| 156 | positive regulation of acute inflammatory response (GO:0002675) | 2.77093648 |
| 157 | detection of other organism (GO:0098543) | 2.76599160 |
| 158 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76596989 |
| 159 | negative regulation of interleukin-17 production (GO:0032700) | 2.75330335 |
| 160 | mast cell degranulation (GO:0043303) | 2.75251027 |
| 161 | mast cell activation involved in immune response (GO:0002279) | 2.75251027 |
| 162 | T cell migration (GO:0072678) | 2.75092568 |
| 163 | detection of bacterium (GO:0016045) | 2.73858126 |
| 164 | lymphocyte migration (GO:0072676) | 2.73218313 |
| 165 | mature B cell differentiation (GO:0002335) | 2.72936668 |
| 166 | positive regulation of cell killing (GO:0031343) | 2.72705620 |
| 167 | T cell differentiation (GO:0030217) | 2.71745196 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.74733060 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.01984712 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.70811934 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.37768508 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.22272161 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.90243578 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.85168704 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.76262035 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71751069 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.42649437 |
| 11 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.41315136 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33473898 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.19324429 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.15949502 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07991960 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.00312202 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68448644 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61196864 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.60602125 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55662657 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53367481 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30246998 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.29419759 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.28770069 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19543590 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.08937920 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01376934 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89840608 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.86628778 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86626271 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86581252 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86055087 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.82171310 |
| 34 | * MYB_26560356_Chip-Seq_TH2_Human | 1.81310069 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79782209 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76143841 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75637025 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73666233 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69635058 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68870286 |
| 41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67738233 |
| 42 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.66890298 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66739327 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64882855 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63779928 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62574924 |
| 47 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.62535221 |
| 48 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.60529157 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59936850 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58834651 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58717246 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57855279 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56438210 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.55273932 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51682163 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47360884 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46783422 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45943793 |
| 59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.45857226 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43581506 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.43425869 |
| 62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36102295 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35679519 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33968807 |
| 65 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.32151741 |
| 66 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30931705 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30263653 |
| 68 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28712342 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27652452 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25828564 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25017683 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.23528401 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23082030 |
| 74 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22157546 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20866930 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19267656 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15803319 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14772075 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13710993 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12620828 |
| 81 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12017116 |
| 82 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10199535 |
| 83 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10199535 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09456436 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07525972 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06182925 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05517084 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05200188 |
| 89 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04943836 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04807054 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04317055 |
| 92 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03776834 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02674125 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01045322 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00731379 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00727041 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00460559 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00076901 |
| 99 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99422587 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98758386 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98107021 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97704147 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97314197 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96382908 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93441153 |
| 106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89469050 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89292991 |
| 108 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89074468 |
| 109 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89074468 |
| 110 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85848162 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84739863 |
| 112 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84618057 |
| 113 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.81747196 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81298680 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80115236 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79870162 |
| 117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79244384 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.79154005 |
| 119 | * MAF_26560356_Chip-Seq_TH2_Human | 0.79030162 |
| 120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78548042 |
| 121 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76025736 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75766154 |
| 123 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.75578045 |
| 124 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75302493 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74820861 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.74211373 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73539474 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72314107 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71207108 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69656274 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69535753 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69028030 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.68563909 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.68129496 |
| 135 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.68043995 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.67683213 |
| 137 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66667333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.33693687 |
| 2 | MP0003436_decreased_susceptibility_to | 4.13215176 |
| 3 | MP0003303_peritoneal_inflammation | 3.83718950 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.69322597 |
| 5 | MP0009785_altered_susceptibility_to | 3.42935892 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.18372048 |
| 7 | MP0002419_abnormal_innate_immunity | 3.14431730 |
| 8 | MP0006082_CNS_inflammation | 3.05494482 |
| 9 | MP0004510_myositis | 2.88214897 |
| 10 | MP0005025_abnormal_response_to | 2.76527208 |
| 11 | MP0003724_increased_susceptibility_to | 2.66296163 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.61261113 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.49993757 |
| 14 | MP0000685_abnormal_immune_system | 2.47656091 |
| 15 | MP0005387_immune_system_phenotype | 2.47422697 |
| 16 | MP0001790_abnormal_immune_system | 2.47422697 |
| 17 | MP0005671_abnormal_response_to | 2.32173758 |
| 18 | MP0002723_abnormal_immune_serum | 2.30480539 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.29644336 |
| 20 | MP0001800_abnormal_humoral_immune | 2.20004286 |
| 21 | MP0001819_abnormal_immune_cell | 2.10257820 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.07201360 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.00794061 |
| 24 | MP0002405_respiratory_system_inflammati | 2.00290809 |
| 25 | MP0003448_altered_tumor_morphology | 1.98847019 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.97820237 |
| 27 | MP0000343_altered_response_to | 1.95455669 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.93622427 |
| 29 | MP0000858_altered_metastatic_potential | 1.85239373 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.82138702 |
| 31 | MP0005310_abnormal_salivary_gland | 1.77731216 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.76205084 |
| 33 | MP0009764_decreased_sensitivity_to | 1.75318004 |
| 34 | MP0001853_heart_inflammation | 1.71389623 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.69639024 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.69088742 |
| 37 | MP0002006_tumorigenesis | 1.66061814 |
| 38 | MP0004947_skin_inflammation | 1.64826204 |
| 39 | MP0003075_altered_response_to | 1.62223449 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.60423497 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.58181739 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.53737338 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.48212533 |
| 44 | MP0005166_decreased_susceptibility_to | 1.47617694 |
| 45 | MP0002009_preneoplasia | 1.46475397 |
| 46 | MP0001873_stomach_inflammation | 1.46409137 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.45344268 |
| 48 | MP0000716_abnormal_immune_system | 1.44381108 |
| 49 | MP0008469_abnormal_protein_level | 1.43085568 |
| 50 | MP0000604_amyloidosis | 1.39775620 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.37698127 |
| 52 | MP0002163_abnormal_gland_morphology | 1.32671446 |
| 53 | MP0002398_abnormal_bone_marrow | 1.31994683 |
| 54 | MP0005390_skeleton_phenotype | 1.29148161 |
| 55 | MP0003186_abnormal_redox_activity | 1.26642480 |
| 56 | MP0006054_spinal_hemorrhage | 1.25128693 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.23034276 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.23034276 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.21622126 |
| 60 | MP0001542_abnormal_bone_strength | 1.21384281 |
| 61 | MP0003279_aneurysm | 1.21088198 |
| 62 | MP0002933_joint_inflammation | 1.19622726 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.19456996 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.18445922 |
| 65 | MP0008260_abnormal_autophagy | 1.17329320 |
| 66 | MP0005164_abnormal_response_to | 1.15370396 |
| 67 | MP0010307_abnormal_tumor_latency | 1.14883856 |
| 68 | MP0002429_abnormal_blood_cell | 1.13249631 |
| 69 | MP0001851_eye_inflammation | 1.09735168 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.09014410 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.08915044 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.08043944 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.07936257 |
| 74 | MP0002722_abnormal_immune_system | 1.06339162 |
| 75 | MP0004858_abnormal_nervous_system | 1.02556745 |
| 76 | MP0003091_abnormal_cell_migration | 1.01302091 |
| 77 | MP0009278_abnormal_bone_marrow | 0.98524167 |
| 78 | MP0009840_abnormal_foam_cell | 0.98180290 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.95845575 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.94710227 |
| 81 | MP0003828_pulmonary_edema | 0.94531341 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.92767152 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.92313661 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.90611226 |
| 85 | MP0004381_abnormal_hair_follicle | 0.88778743 |
| 86 | MP0002132_abnormal_respiratory_system | 0.87578425 |
| 87 | MP0003795_abnormal_bone_structure | 0.87041173 |
| 88 | MP0000249_abnormal_blood_vessel | 0.86505013 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.85918026 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.85861974 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.84675538 |
| 92 | MP0009763_increased_sensitivity_to | 0.82837984 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.81057359 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.80027376 |
| 95 | MP0003690_abnormal_glial_cell | 0.77040261 |
| 96 | MP0004883_abnormal_blood_vessel | 0.76387298 |
| 97 | MP0000490_abnormal_crypts_of | 0.75623957 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.75352908 |
| 99 | MP0005451_abnormal_body_composition | 0.74262094 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.74141493 |
| 101 | MP0003045_fibrosis | 0.74010848 |
| 102 | MP0001663_abnormal_digestive_system | 0.71746075 |
| 103 | MP0001958_emphysema | 0.69888857 |
| 104 | MP0005408_hypopigmentation | 0.69059876 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.68727748 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.68454206 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.66971173 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.66950297 |
| 109 | MP0005197_abnormal_uvea_morphology | 0.65701615 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.64942001 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.64874245 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.64796125 |
| 113 | MP0005023_abnormal_wound_healing | 0.64066311 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.63844172 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.63160112 |
| 116 | MP0001919_abnormal_reproductive_system | 0.62792278 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.62246694 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.60128394 |
| 119 | MP0002396_abnormal_hematopoietic_system | 0.59497234 |
| 120 | MP0003866_abnormal_defecation | 0.58436430 |
| 121 | MP0002653_abnormal_ependyma_morphology | 0.57450585 |
| 122 | MP0004808_abnormal_hematopoietic_stem | 0.57195992 |
| 123 | MP0001764_abnormal_homeostasis | 0.55278613 |
| 124 | MP0008873_increased_physiological_sensi | 0.49897841 |
| 125 | MP0001243_abnormal_dermal_layer | 0.47882277 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.42971631 |
| 127 | MP0003786_premature_aging | 0.42060095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.34269020 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.33236602 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.64267662 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.01524952 |
| 5 | T lymphocytopenia (HP:0005403) | 5.01075296 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.81051110 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.77037804 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.75692611 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.75459789 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.69850835 |
| 11 | IgG deficiency (HP:0004315) | 4.51343814 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 4.47722484 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.29369036 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.23349179 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 4.19139004 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.13369842 |
| 17 | Combined immunodeficiency (HP:0005387) | 4.12250943 |
| 18 | Myositis (HP:0100614) | 4.09553772 |
| 19 | Abnormality of B cell number (HP:0010975) | 4.01122811 |
| 20 | Recurrent skin infections (HP:0001581) | 4.00406888 |
| 21 | Obstructive lung disease (HP:0006536) | 3.90502548 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.90502548 |
| 23 | Abnormality of T cells (HP:0002843) | 3.89323453 |
| 24 | Axonal loss (HP:0003447) | 3.88501185 |
| 25 | B lymphocytopenia (HP:0010976) | 3.87513487 |
| 26 | Orchitis (HP:0100796) | 3.85077977 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.85001619 |
| 28 | Gingivitis (HP:0000230) | 3.73319868 |
| 29 | Encephalitis (HP:0002383) | 3.67377366 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.64568609 |
| 31 | Prostate neoplasm (HP:0100787) | 3.56469496 |
| 32 | Eosinophilia (HP:0001880) | 3.54107672 |
| 33 | Granulocytopenia (HP:0001913) | 3.51857905 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.51494632 |
| 35 | Agammaglobulinemia (HP:0004432) | 3.48506786 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.45812411 |
| 37 | Optic neuritis (HP:0100653) | 3.45812411 |
| 38 | Abnormality of eosinophils (HP:0001879) | 3.43581990 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.42809051 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.36938186 |
| 41 | Thyroiditis (HP:0100646) | 3.23708206 |
| 42 | Cellulitis (HP:0100658) | 3.22734793 |
| 43 | IgM deficiency (HP:0002850) | 3.16483335 |
| 44 | Disinhibition (HP:0000734) | 3.08764021 |
| 45 | Stomatitis (HP:0010280) | 3.08538853 |
| 46 | Vasculitis (HP:0002633) | 3.05835453 |
| 47 | Lymphopenia (HP:0001888) | 3.02671765 |
| 48 | Vertebral compression fractures (HP:0002953) | 3.02462451 |
| 49 | Basal ganglia calcification (HP:0002135) | 3.01154104 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97395002 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97395002 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97395002 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.97093430 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.93704447 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.86894270 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84808438 |
| 57 | Peritonitis (HP:0002586) | 2.78672754 |
| 58 | Glomerulonephritis (HP:0000099) | 2.75593784 |
| 59 | Urticaria (HP:0001025) | 2.70413511 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67297381 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67297381 |
| 62 | Recurrent viral infections (HP:0004429) | 2.64949974 |
| 63 | Lymphoma (HP:0002665) | 2.62692997 |
| 64 | Chronic diarrhea (HP:0002028) | 2.59962999 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.59404278 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.57873689 |
| 67 | Hypoproteinemia (HP:0003075) | 2.56792387 |
| 68 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56760587 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.55542415 |
| 70 | Pustule (HP:0200039) | 2.53075493 |
| 71 | Myocardial infarction (HP:0001658) | 2.51019916 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.48750292 |
| 73 | Thick nail (HP:0001805) | 2.46106739 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45757578 |
| 75 | Increased IgM level (HP:0003496) | 2.45495507 |
| 76 | Osteomyelitis (HP:0002754) | 2.42407454 |
| 77 | Periodontitis (HP:0000704) | 2.41800545 |
| 78 | Verrucae (HP:0200043) | 2.40902619 |
| 79 | Papilloma (HP:0012740) | 2.40902619 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.39016162 |
| 81 | Hypoplasia of the thymus (HP:0000778) | 2.36543076 |
| 82 | Tetraparesis (HP:0002273) | 2.34489911 |
| 83 | Neoplasm of head and neck (HP:0012288) | 2.33563968 |
| 84 | Esophageal neoplasm (HP:0100751) | 2.33563968 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.32666608 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32666608 |
| 87 | Meningitis (HP:0001287) | 2.31462617 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31133623 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.31133623 |
| 90 | Petechiae (HP:0000967) | 2.30755043 |
| 91 | Poor head control (HP:0002421) | 2.28713583 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 2.28520429 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.28201739 |
| 94 | Arterial thrombosis (HP:0004420) | 2.26761834 |
| 95 | Colitis (HP:0002583) | 2.26665929 |
| 96 | Leukocytosis (HP:0001974) | 2.23909215 |
| 97 | Chest pain (HP:0100749) | 2.23011898 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.22633503 |
| 99 | Acute hepatic failure (HP:0006554) | 2.21960957 |
| 100 | Gangrene (HP:0100758) | 2.20355174 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17916930 |
| 102 | Aplastic anemia (HP:0001915) | 2.17203563 |
| 103 | IgA deficiency (HP:0002720) | 2.14936909 |
| 104 | Joint swelling (HP:0001386) | 2.12430387 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.11781287 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10536629 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10536629 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10536629 |
| 109 | Abnormality of the lumbar spine (HP:0100712) | 2.09650345 |
| 110 | Agnosia (HP:0010524) | 2.08913599 |
| 111 | Abnormality of the prostate (HP:0008775) | 2.08839658 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 2.07545541 |
| 113 | Hemoptysis (HP:0002105) | 2.05190620 |
| 114 | Nephritis (HP:0000123) | 2.04405101 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04294484 |
| 116 | Bone pain (HP:0002653) | 2.02425631 |
| 117 | Bone cyst (HP:0012062) | 1.99532492 |
| 118 | Pathologic fracture (HP:0002756) | 1.97234171 |
| 119 | Abnormality of the pericardium (HP:0001697) | 1.95016424 |
| 120 | Polyneuropathy (HP:0001271) | 1.93828145 |
| 121 | Loss of speech (HP:0002371) | 1.91865061 |
| 122 | Glomerulopathy (HP:0100820) | 1.89247477 |
| 123 | Abnormality of complement system (HP:0005339) | 1.89004294 |
| 124 | Fatigue (HP:0012378) | 1.88531939 |
| 125 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.87976937 |
| 126 | Anorexia (HP:0002039) | 1.86278344 |
| 127 | Skin rash (HP:0000988) | 1.85872561 |
| 128 | Thrombocytosis (HP:0001894) | 1.83363524 |
| 129 | Epistaxis (HP:0000421) | 1.81916187 |
| 130 | Nasal polyposis (HP:0100582) | 1.81170522 |
| 131 | Chronic otitis media (HP:0000389) | 1.80829844 |
| 132 | Neutropenia (HP:0001875) | 1.80373782 |
| 133 | Chronic sinusitis (HP:0011109) | 1.79659728 |
| 134 | Bronchitis (HP:0012387) | 1.79013019 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.78856751 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.78016877 |
| 137 | Sepsis (HP:0100806) | 1.75660111 |
| 138 | Spontaneous hematomas (HP:0007420) | 1.75434272 |
| 139 | Premature loss of primary teeth (HP:0006323) | 1.75429501 |
| 140 | Skin ulcer (HP:0200042) | 1.75400185 |
| 141 | Stomach cancer (HP:0012126) | 1.74832693 |
| 142 | Arthralgia (HP:0002829) | 1.73956190 |
| 143 | Beaking of vertebral bodies (HP:0004568) | 1.73926427 |
| 144 | Alveolar cell carcinoma (HP:0006519) | 1.73596433 |
| 145 | Diminished motivation (HP:0000745) | 1.72729786 |
| 146 | J-shaped sella turcica (HP:0002680) | 1.71143529 |
| 147 | Anhidrosis (HP:0000970) | 1.70964620 |
| 148 | Porencephaly (HP:0002132) | 1.70805329 |
| 149 | Thoracic kyphosis (HP:0002942) | 1.69966779 |
| 150 | Keratoconjunctivitis (HP:0001096) | 1.68526001 |
| 151 | Spondylolisthesis (HP:0003302) | 1.67571484 |
| 152 | Hematochezia (HP:0002573) | 1.67494913 |
| 153 | Increased IgE level (HP:0003212) | 1.62124239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.83071559 |
| 2 | BLK | 3.81819474 |
| 3 | NME2 | 3.75747781 |
| 4 | RIPK4 | 3.72304104 |
| 5 | PIM2 | 3.28413199 |
| 6 | PBK | 3.09067680 |
| 7 | TBK1 | 2.88301545 |
| 8 | PASK | 2.51722618 |
| 9 | MAP4K1 | 2.27709474 |
| 10 | IRAK4 | 2.27000856 |
| 11 | TYK2 | 2.24109683 |
| 12 | GRK6 | 2.18659989 |
| 13 | JAK3 | 2.02213689 |
| 14 | ERN1 | 2.00159585 |
| 15 | ABL2 | 1.96468451 |
| 16 | IKBKB | 1.93425862 |
| 17 | TXK | 1.82846427 |
| 18 | KDR | 1.81917962 |
| 19 | TESK1 | 1.79144862 |
| 20 | ZAP70 | 1.76118121 |
| 21 | ARAF | 1.74948856 |
| 22 | IKBKE | 1.74878847 |
| 23 | NEK9 | 1.64303294 |
| 24 | KIT | 1.63834301 |
| 25 | TLK1 | 1.61977508 |
| 26 | TAOK3 | 1.58354494 |
| 27 | SCYL2 | 1.58305850 |
| 28 | MAP3K11 | 1.40468436 |
| 29 | MAP3K13 | 1.35196356 |
| 30 | MOS | 1.34286511 |
| 31 | IRAK3 | 1.33652357 |
| 32 | TRPM7 | 1.31557932 |
| 33 | CAMKK1 | 1.30753486 |
| 34 | PRPF4B | 1.29098104 |
| 35 | JAK1 | 1.28709252 |
| 36 | BMPR2 | 1.27649604 |
| 37 | TESK2 | 1.26622601 |
| 38 | SYK | 1.25726671 |
| 39 | MST4 | 1.24764028 |
| 40 | HCK | 1.24458832 |
| 41 | CSK | 1.18982554 |
| 42 | RPS6KA4 | 1.18730120 |
| 43 | EPHB1 | 1.17177629 |
| 44 | CDK19 | 1.10622549 |
| 45 | BMX | 1.08279453 |
| 46 | CHUK | 1.02681039 |
| 47 | BTK | 1.02469122 |
| 48 | LIMK1 | 1.01509247 |
| 49 | GRK7 | 1.00333846 |
| 50 | TNK2 | 0.96224204 |
| 51 | LYN | 0.94796130 |
| 52 | PIM1 | 0.94578714 |
| 53 | STK10 | 0.94249812 |
| 54 | NLK | 0.93805592 |
| 55 | TEC | 0.93255571 |
| 56 | LCK | 0.92374205 |
| 57 | KSR2 | 0.90658175 |
| 58 | TTN | 0.90467007 |
| 59 | MAP2K3 | 0.88960962 |
| 60 | FGR | 0.88807072 |
| 61 | FES | 0.88536981 |
| 62 | VRK2 | 0.88448227 |
| 63 | JAK2 | 0.88361310 |
| 64 | CSF1R | 0.87652126 |
| 65 | ZAK | 0.87626976 |
| 66 | EIF2AK3 | 0.86020617 |
| 67 | EPHA3 | 0.84213773 |
| 68 | MAP3K5 | 0.80138071 |
| 69 | MATK | 0.77461502 |
| 70 | MARK3 | 0.77347342 |
| 71 | CAMKK2 | 0.77239032 |
| 72 | BCKDK | 0.76103144 |
| 73 | LRRK2 | 0.75331307 |
| 74 | FGFR3 | 0.74637448 |
| 75 | MST1R | 0.73938654 |
| 76 | ERBB4 | 0.73544454 |
| 77 | NTRK1 | 0.72942160 |
| 78 | VRK1 | 0.70572015 |
| 79 | ABL1 | 0.70502356 |
| 80 | MAP3K3 | 0.69336390 |
| 81 | MAP3K1 | 0.67569715 |
| 82 | TAOK2 | 0.66896617 |
| 83 | EIF2AK2 | 0.66850474 |
| 84 | ERBB3 | 0.64753789 |
| 85 | GRK5 | 0.63066609 |
| 86 | YES1 | 0.62632834 |
| 87 | TAOK1 | 0.61898147 |
| 88 | CDK6 | 0.60089365 |
| 89 | STK4 | 0.59484492 |
| 90 | PRKCD | 0.58962887 |
| 91 | TGFBR2 | 0.57929168 |
| 92 | MAP3K10 | 0.56877808 |
| 93 | SIK2 | 0.56093475 |
| 94 | DAPK3 | 0.53347094 |
| 95 | CDK4 | 0.53229002 |
| 96 | EGFR | 0.51889709 |
| 97 | MAP3K12 | 0.51796269 |
| 98 | MAPKAPK2 | 0.51793165 |
| 99 | IRAK1 | 0.51758618 |
| 100 | MAPK11 | 0.50955235 |
| 101 | RAF1 | 0.48663798 |
| 102 | HIPK2 | 0.46928942 |
| 103 | RPS6KA5 | 0.44934334 |
| 104 | DMPK | 0.43804175 |
| 105 | ADRBK2 | 0.41098953 |
| 106 | PIK3CG | 0.40826047 |
| 107 | MAP4K2 | 0.39651913 |
| 108 | TRIM28 | 0.38413966 |
| 109 | CLK1 | 0.37855099 |
| 110 | TRIB3 | 0.37593249 |
| 111 | ILK | 0.36474734 |
| 112 | RIPK1 | 0.35981363 |
| 113 | SIK3 | 0.35732157 |
| 114 | ITK | 0.35364887 |
| 115 | BRAF | 0.34754354 |
| 116 | MAP3K8 | 0.34649752 |
| 117 | TIE1 | 0.33919359 |
| 118 | PAK4 | 0.33422581 |
| 119 | MAPK7 | 0.33344699 |
| 120 | MAP2K1 | 0.33295427 |
| 121 | RPS6KA6 | 0.32042570 |
| 122 | PTK2B | 0.31984299 |
| 123 | PAK1 | 0.29635224 |
| 124 | MAP2K2 | 0.29500518 |
| 125 | PRKCQ | 0.28806553 |
| 126 | FYN | 0.27133377 |
| 127 | NUAK1 | 0.27063170 |
| 128 | DAPK1 | 0.25046415 |
| 129 | PDK1 | 0.23132129 |
| 130 | IGF1R | 0.21833697 |
| 131 | INSR | 0.20615875 |
| 132 | STK24 | 0.20195912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.48068837 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84057892 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.57901993 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52923375 |
| 5 | Phagosome_Homo sapiens_hsa04145 | 2.50430393 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44751994 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.44619239 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44075814 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.40381326 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.39762350 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.26266359 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22741268 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19518044 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.10090015 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 2.09377189 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 2.08391114 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 2.07050409 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.89719961 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.83957164 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.79091869 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76401455 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.71954546 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69394125 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.68067424 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62080525 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.60158682 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56712696 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52839796 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51802929 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.50909688 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48473624 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47172345 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.46831507 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.42825745 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42128617 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32320551 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29820242 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29237912 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28322041 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25130313 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23540202 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23221979 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15433528 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.11841631 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11421021 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10710629 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08075790 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05775971 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04702190 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04356650 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01479724 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.01060760 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.00389005 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00060212 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97176493 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93191080 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91830922 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91666667 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.90495693 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90199033 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85379500 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.83005785 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74542113 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73718826 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70451564 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69674812 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.68676306 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68327245 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.67401837 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.67167375 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.65371753 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64662088 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64468924 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62893242 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62438608 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61245304 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.61031922 |
| 78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60782693 |
| 79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59639336 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59243415 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.56130483 |
| 82 | Homologous recombination_Homo sapiens_hsa03440 | 0.53600156 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53459219 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50463226 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49828675 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48121093 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46625623 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.45778124 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45744467 |
| 90 | Mismatch repair_Homo sapiens_hsa03430 | 0.45395720 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42616813 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40904043 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40731054 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39153152 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36185033 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36121213 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36113827 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.35824803 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34342953 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33761030 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32908801 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31573859 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30298050 |
| 104 | Protein export_Homo sapiens_hsa03060 | 0.29173633 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28040439 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27658083 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26033427 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24944604 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24758609 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.24573923 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23603977 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23400167 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22907115 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21619106 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.21474324 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.21007972 |
| 117 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20828475 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.20046344 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19736539 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19491839 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.18465800 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.17198408 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.16820015 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15720293 |
| 125 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.14275518 |
| 126 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.13352284 |

